Moreover, potential applications of nanomedicine in cancer and autoimmunity are further extended by use of artificial antigen-presenting cells (APCs), which are assembled on nanoscale scaffolds with co-stimulatory molecules and MHC-peptide complexes, allowing a precise control of T-cell repertoires [26]. This evidence concerns the gene HLA-C and Autoimmunity.